|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-12-12
|
|
pubmed:abstractText |
Although an analgesic effect is an essential component of the mode of action of bisphosphonates, its physiological mechanisms are still unclear. Beta-endorphin release plays an important role in the analgesic effect of both calcitonin and raloxifene. As patients with Paget's disease receive large doses of bisphosphonates within relatively short time periods, we examined whether repeated pamidronate infusion therapy would cause measurable change in beta-endorphin levels
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0172-780X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
513-5
|
|
pubmed:meshHeading |
pubmed-meshheading:16891991-Aged,
pubmed-meshheading:16891991-Analgesics,
pubmed-meshheading:16891991-Bone Density Conservation Agents,
pubmed-meshheading:16891991-Diphosphonates,
pubmed-meshheading:16891991-Female,
pubmed-meshheading:16891991-Humans,
pubmed-meshheading:16891991-Infusions, Intravenous,
pubmed-meshheading:16891991-Male,
pubmed-meshheading:16891991-Middle Aged,
pubmed-meshheading:16891991-Osteitis Deformans,
pubmed-meshheading:16891991-Pain,
pubmed-meshheading:16891991-Pain Measurement,
pubmed-meshheading:16891991-Pilot Projects,
pubmed-meshheading:16891991-beta-Endorphin
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The analgesic effect of pamidronate is not caused by the elevation of beta endorphin level in Paget's disease--a controlled pilot study.
|
|
pubmed:affiliation |
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest, Hungary. bender@mail.datanet.hu
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
